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Summary 
A chimeric class I glycoprotein was created to investigate the functional contribution of the c~ 
helices and the 3-pleated sheets in forming the antigen recognition site (ARS) of antigen-presenting 
molecules. This novel molecule was generated by replacing the DNA sequences encoding the 
ot helices of the L d gene with the corresponding sequences from the K b gene. Serologic analysis 
of transfected L cells that expressed the chimeric molecule (KbL~) revealed that the engineered 
class I glycoprotein retains two conformational epitopes associated with the c~ helices of K  b, 
as defined by monoclonal antibodies K10.56  and 28-13-3. These results demonstrate that the 
cr helices of K b can associate with the 3-pleated sheets of L  a to form a stable structure, which 
is expressed on the cell surface. To address the role of the ot helices of the ARS in determining 
T cell crossreactivity, alloreactive cytotoxic T lymphocytes (CTL) were used to analyze L cells 
expressing  b  d  K,~La. CTL raised against K  b or L  d as alloantigens showed little, if any, ability to 
lyse L cells expressing  b  a  K,~La. Thus, alloreactive CTL did not recognize structures  determined 
by the ot helices alone or by the 3 sheets of the ARS alone. However, bulk and cloned alloreactive 
b  d  bm8  CTL that were generated against the mutant K  b glycoprotein K  reacted strongly with K~La. 
In addition to  the K  b cr  helices, the K  bin8 ARS shares a single polymorphic amino acid at 
b  d  position 24 with K,~La. Amino acid 24 is located on the 32 strand that forms part of the floor 
of the ARS and has been identified as a component of pocket B in the HLA class I ARS. The 
substitution of Glu to Ser at this position was shown previously to be the central determinant 
bm8  .....  of the K  mutant alloantlgemclty. The functional significance of this position in determining 
crossreactivity between bm8 and KbL~ identifies pocket B as a strong anchor for allogenic self- 
peptides. These findings demonstrate that determinants recognized by CTL on class I aUoantigens 
are formed by interactions involving both the ot helices and 3 sheets of the ARS. These interactions 
are best explained by the influence of the ot helices and 3 sheets on the peptide-binding properties 
of these antigen-presenting molecules. 
D 
iscerning the molecular basis of the interactions between 
MHC class I glycoproteins and TCRs is central to un- 
derstanding  both antigen-specific and alloreactive immune 
responses. Current models explain alloreactivity at the mo- 
lecular level in the context of the three-dimensional  crystal 
structure of HLA-A2 (1). According to this view, T cell al- 
loreactivity  is caused by an altered antigen recognition site 
(ARS) 1 along the top face of polymorphic class I glycopro- 
teins. The polymorphic amino acids whose side chains im- 
pinge on the ARS alter the orientation and spectrum of self- 
peptides presented to T cells by the class I glycoproteins (2). 
1 Abbreviation used in this paper: AtLS, antigen recognition site. 
The altered orientation and spectrum of selfopeptides may 
account for the activation of a high proportion of the avail- 
able T cell repertoire (3, 4). The importance of amino acid 
side chains oriented into the ARS with regard to alloreac- 
tivity has been tested by site-directed  mutagenesis (5-9). These 
investigations confirm that natural polymorphisms in amino 
acid side  chains oriented away from the ARS are silent, while 
amino acids with side  chains oriented into the ARS influence 
alloreactivity. 
An added component of complexity to allorecognition 
comes from the polymorphic amino acids located on the ot 
helices with side chains oriented outward from the top face 
of the class I glycoprotein (2). These amino acids may influence 
alloreactivity  without altering self-peptides  bound in the ARS 
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interactions between MHC molecules and the TCK could 
result in allorecognition (2,  3, 4,  10). Alloreactive T  cells 
could respond to the polymorphic amino acids located in the 
ot helices, which are directly accessible to TCR binding. Some 
T cells may recognize peptides in the ARS with no interac- 
tion with the ot helices being necessary. Still other T  cells 
may require a combination of altered self-peptide  and inter- 
action with the ot helices  for allorecognition to occur. 
To investigate the role of the o~-helical regions of the ARS 
in allorecognition, we constructed a chimeric class I protein 
using a novel technique based upon the PCK (11). Using this 
technique, a new MHC class I molecule was designed in which 
the DNA encoding the ot helices of K  b have been spliced 
into the L d gene. The protein expressed by this construct has 
a chimeric ARS with K b cz helices and L  d 3-pleated sheets 
(KbL~). This new class I construct was expressed in L cells 
and analyzed serologically with a panel ofmAbs and for cell- 
mediated crossreactivity using a series of alloreactive  CTL. 
Materials  and Methods 
Mice.  Mice  used in these studies that were purchased from 
The Jackson Laboratories (Bar Harbor, ME) were C57BL/6ByJ 
(H-2b), B6.C-H-2~I~  (bml0), B6.C-H-2bmn/KhEg  (bin11), 
C57BL/6J-H2b~/KhEg (bin5), B6.C-H-2bmVByJ (bin1), C57"BL/ 
6Kh-H-2~/KhEg (bmf), C3H/HeJ (H-2k), and C3H.SW (H-2b). 
B10.GD/DfDv (H-2~), B10.AQR/KIDv (H-27t), and B10.RQDB 
(H-2  qa81) recombinant mice were obtained from Dr. Chella David's 
Immunogenetic colony at the Mayo Clinic (Rochester, MN). 
Monodonal Antibodies.  The origin and specificity  of the H-2K  b- 
reactive mAbs K10.56 (3,2b,  x) and B8-24-3 ('gla,~), as wen as the 
H-2La-reactive mAbs 64-3-7 (~/la,g), 30-5-7 (3,2a,g), and 28-14-8 
(3,2a,g), were described previously (12-17). 
Immunofluorescence Analysis.  The serologic  profile of the trans- 
fected  L cell  lines  were determined  as previously  described  (8). Briefly, 
L cells were incubated with either the spedfic mAb or an isotype 
control for 30 min on ice. The ceUs were then washed three times 
with HBSS containing 0.2% Na-azide and 1% BSA. The washed 
cells were incubated with an appropriate dilution of FITC-con- 
jugated goat anti-mouse antibody (Tago, Inc., Burlingame, CA). 
Viable ceUs, as determined by exclusion  of  propidium iodide exclu- 
sion, were analyzed on a FACS IV  |  (Becton Dickinson & Co., 
Mountain View, CA). 
Construction of the Chimeric Class I Gene.  The chimeric class 
I gene was constructed by splicing  the DNA encoding the c~ helices 
from the K  s gene to DNA encoding the 3-pleated sheets of L  d. 
K  b and L  a were chosen for the construction, because these two 
molecules differ at virtuaUy all polymorphic positions on the 
strands that form the floor of the ARS and by 10 amino acids along 
the c~ helices that influence peptide binding and/or that interact 
directly with the TCR (Fig. 1). The chimera was assembled  using 
the PCR-based method (11) of splicing by overlap extension. The 
ollgonudeotide primers used for constructing the chimeric gene 
are listed in Table 1 along with the corresponding region that each 
pair of  primers amplified.  The four individual  PCR fragments (1-4) 
were amplified and gd purified using Gene Clean (Bio 101, Inc., 
La  Jolla, CA). In a separate PCR, the first fragment corresponding 
to the first intron to amino acid 50 of L  a was fused to the second 
fragment corresponding to amino acids 50-87 of K  b using the 
flanking primers A and D. Similarly, the third fragment corre- 
sponding to amino acids 87-129 of L  a was fused to the fourth 
fragment corresponding to amino acids 129-181 of K  b using the 
flanking primers E and H. These two fragments were then gel 
purified and fused in a final PCR using primers A and H to create 
the chimeric construct consisting of DNA encoding the cz helices 
of K  b and the 3-pleated sheets of L a (KbL~). The construct was 
cloned into the class I expression vector described by Pulhn et al. (8) 
and sequenced before transfection. 
L Cell Transfection.  The K~L~  construct was transfected  into L 
cells (H-2  k) using the calcium phosphate method as previously  de- 
scribed (8). L cells expressing K  b,  K  bms, K  bins-z2, K  bms-za, and 
K  bins-23,3~ have been described previously (8, 9). 
Generation Of CTL and Analysis of L Cells by S'Cr Releas~  CTL 
lines were generated as described  previously  (8, 9). Briefly,  primary 
CTLs were generated by coculture of equal numbers (5  x  106) 
of responder and irradiated (3,000 rad) stimulator ceils in 2 ml of 
complete medium (KPMI 1640, 10% FCS, 5  x  105 2-ME, 0.4 
mM L-glutamine,  40 U/ml penicillin "G'" 50 #g/ml streptomycin 
sulfate) using 24-well plates. After 5 d, cytotoxic activity was mea- 
sured using a standard SlCr release assay. CTL specific for the 
stimulating strain and with low background lysis  of targets bearing 
self-antigens were cultured continuously by restimulation every 
7-10 d in media  containing 5 U/ml rib2 (Amgen Biologicals,  Thou- 
sand Oaks, CA). Some  bulk CTL lines were doned at five  cells/weU 
in 96-well plates. To determine cell lysis, transfected L cell targets 
were labeled with 100 #Ci of sodium [SICr]chromate  (Amersham 
Corp.,  Arlington  Heights, IL) per 106 cells. Labeled cells were 
washed three times and 5  x  103 ceils were incubated with serial 
dilutions of effector CTL in 200/A of complete medium using 96- 
well round-bottomed plates. After a brief centrifugation,  phtes were 
incubated for 8 h at 37~  supernatants were harvested, and radio- 
activity was determined. Maximum release of  radioactivity  was de- 
termined by detergent lysis (1% Triton X-100) and specific lysis 
was calculated using the formula: percent specific lysis =  (cpm 
released by CTL -  cpm of spontaneous release)/(cpm released by 
detergent -  cpm of  spontaneous release). Spontaneous  release was 
<20% of detergent lysis in all experiments. 
Results 
Surface Expression and Structural Integrity  of K~L~  The 
ability of the chimeric protein encoded by the KbaL~  con- 
struct to fold properly and be expressed on the cell surface 
in a functional form is critical for the analysis of its alloanti- 
genic properties.  The surface expression  and structural in- 
tegrity of KbL~ was assessed using mAbs that recognize con- 
formationaUy dependent epitopes in conjunction with a mAb 
that can provide conformationally  independent measurements. 
The class I vector used to express K~L~ in L cells incor- 
porates the o~3 domain of L  d, which determines the anti- 
body epitope detected by mAb 28-14-8. The L  a or3 domain 
is  expressed  on  the  cell  surface  in  the  absence  of  /52- 
microglobulin or in the absence of functional od and oe2 do- 
mains (16). Since the ol3 domain of L a is expressed promis- 
cuously on the cell surface, the 28-14-8 epitope can be used 
b  d  to monitor the level of protein expression by the K,,Lt~  con- 
struct regardless  of any changes in folding patterns created 
by generating an cd and o~2 chimera. 
The serologic epitope identified by mAb K10.56 is depen- 
dent on amino acids in both the od and o~2 helices of K b 
as well as by the amino acids on the 3  sheets forming the 
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Figure 1.  Structural  differences between K  b and L  d. The position of the amino acid differences in the oll and ol2 domains  between K  b and L  d are 
displayed by circles on the class I ribbon diagram.  The solid circles indicate  amino acid positions  with the potential to influence ligand binding or 
TCR interactions  with the c~ helices. The open circles indicate amino acid positions  predicted  to be silent with regard  to ligand binding and TCR 
interaction.  (.4) Differences in the amino acids on the 3  sheets that form the floor of the ARS. The first single-letter  code identifies the K b amino 
acid followed by the single-letter  code for the amino acid found in L  d. (/3)  Differences in the amino acids along the o~ helices. The first single-letter 
code identifies the La amino acid followed by the single-letter  code for the amino acid found  in K  b. In both panels, only the single-letter  codes for 
amino acids predicted to alter ligand binding or TCR interaction are identified. Note that the second amino acid indicated in each case is present in the chimera. 
floor of the antigen binding site (Pease et al., manuscript in 
preparation).  Similarly, the epitope identified by mAb 28- 
13-3 is determined by amino acids in the ce2 helix and by 
the B sheets of the ARS. Interestingly,  the identified amino 
acids that are important in determining these epitopes con- 
tain side chains that are oriented into the antigen recogni- 
tion site and, therefore, probably influence the structure of 
the surface of the molecules indirectly. Amino acid substitu- 
tions at these conformationally interactive sites can in some 
cases disrupt the conformation of glycoproteins even though 
they represent normal structural polymorphisms of functional 
antigen-presenting molecules. 
The structural integrity of the KbL~ chimera was assessed 
by comparing the relative expression of the epitopes detected 
by mAbs K10.56 and 28-13-3 with the epitope encoded in 
the c~3 domain with 28-14-8. The results  of this analysis 
showed that these two conformational epitopes were expressed 
similarly by K b and KbL~ (Table 2). While  b  a  K~Lo bound the 
mAbs with conformationally sensitive epitopes, another K b- 
specific mAb (B8-24-3), which recognizes an epitope deter- 
Table  1.  Oligonucleotides  Used  for Fusing K~La# 
Fragment  5' Oligonucleotide primer  3' Oligonucleotide primer  Template  Amplified  region 
1  (A)  (B)  L  d  First  intron to 
5'GCGTCCTCGGGTCAACCACCGGACCC  5'CGCGCCTGCGGCTCATA  amino acid 50 
2  (C)  (D)  K b  Amino acids 45-87 
5'TATGAGCCGCAGGCGCG  5'GGTTGTAGTAGCCGAGCA 
3  (E)  (F)  L  d  Amino acids 82-129 
5'TGCTCGGCTACTACAACC  5'CTTCGTTCAGGC~GATG 
4  (G)  (H)  K  b  Amino acid 124 to 
5'CATCGCCCTGAACGAAG  5'CCTGC~CACTCTCGAGGGAGAAGGCT  third intron 
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Cell lines  28-14-8  K10.56  28-13-3  B8-24-3  30-5-7  64-3-7 
K b  171  162  ND  175  42  45 
L d  144  44  ND  42  141  159 
b  d  K~L~  168  168  ND  46  42  44 
28-14-8  K10.56  28-13-3  IgG2a  IgG2b  IgM 
K b  186  197  183  37  39  44 
b  d  K~Lo  177  185  165  38  51  47 
mined in part by the loop connecting the ot helix with the 
3-pleated sheets (8),  did not bind the chimera. The mAb 
30-5-7 that recognized an epitope determined by the displaced 
Laot2 helix (our unpublished observation), and an epitope 
recognized by mAb 64-3-7,  which has been reported to be 
associated with L  d molecules that contain empty ARS (17), 
also did not bind to the chimeric glycoprotein. Thus, the 
serologic profile of the expressed molecules was consistent 
with the designed construct, and the conformation of the 
chimeric class I protein encoded by  b  d  KaL  e appeared  to be 
intact. 
Failure of K b- or Ld-specific CTL to Recognize K~L~  CTL 
were raised against the K b and L  a alloantigens to determine 
whether they could recognize epitopes formed primarily by 
the o~ helices or by the 3 sheets of the AKS (Fig. 2). B10.GD 
(Kd,D b) anti-B6 (Kb,D b) CTL lysed L cells expressing the 
K b AKS efficiently, but did not lyse L cells expressing K~L~ 
above  background.  Similarly,  C3H(KkD k)  anti-C3H.SW 
(KbD  b) CTL lysed cells expressing K b but not those expres- 
sing the chimera. B10.KQDB  (Kq,Da,D b)  anti-B10.AQK 
(Kq,Dd,L  a) CTL lysed L cells expressing L  d but also failed 
to lyse the cells expressing K~L~. Together, these three CTL 
populations provided evidence that the alloantigenic struc- 
tures recognized by T cells are not determined by either the 
b  d  ot helices nor by the 3  sheets of K~L  B acting alone. 
In an attempt to focus CTL recognition on specific regions 
of the K b molecule, a  series of bm mutants (bml,  bin8, 
bml0, and bm11) was used to generate anti-K  b (B10) CTL. 
Three of the CTL lines used in this study were raised against 
epitopes determined by amino acid differences located directly 
b  bml  b  bml0  b  on the K  ot helices (18) (K  anti-K , K  anti-K , and 
K bm11 anti-Kb). Since K~,L~ shares the helical structures with 
K b, these CTL in particular might be expected to crossreact 
with the chimera, if the ot helices themselves were capable 
of forming antigenic determinants recognized by T cells. The 
panel of mutant anti-K  b CTL lysed L cells that expressed 
K b, but failed to lyse cells expressing  b  a  K~L~ (Fig.  3). This 
pattern of recognition was consistent with the pattern seen 
using fully allogeneic  CTL and demonstrates directly that 
the alloantigenicity of the K b molecule was not determined 
to any significant  extent by the c~ helices alone. 
b  d  Lysis of K,~L  B by B6 Anti-bin8 CTL.  The mutation in 
r  l'Y  , 
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Figure 2.  Anti-K  b or anti-L  d CTL 
lines fail to recognize  the chimera. Pri- 
mary CTL cultures generated in vitro 
against K  b (B10.GD anti-B6 and C3H 
anti-C3H.SW)  and  L  d (B10.RQDB 
anti-B10.AQR) were used to analyze  L 
cells cotransfected with K  b, L  d, KbL~ 
or herpes thymidine kinase gene alone 
(Ltk). 
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Figure 3.  K b mutant anti-K  b CTL lines fail to recog- 
b  a  The bm mutants  (bml,  bin8,  nize the chimera  K~L~. 
bml0, and bin11) were used to generate effector cells against 
defined regions of K b (B10) heavy chain and used to ana- 
lyze cotransfected L cells. The B10 anti-C3H (anti-H-2K) 
was used to determine lytic potential of the L cell (H-2K) 
target cells. 
bm8 consists of four amino acid substitutions at residues 22, 
23, 24, and 30. In a previous report, we identified the amino 
acid substitutions in residues 22 and 24 as the determinants 
of aUoreactivity between K b and K bins (9). The substitutions 
at 23 and 30 were silent.  Of the two productive substitu- 
tions,  the Glu (K  b) to Set (K  bms) change at  24 dominated 
the  K bms phenotype,  with  the  substitution  at  22  (Try  to 
Phe) having minor effects.  Amino acids 22 and 24 lie adja- 
cent to or inside (respectively), a subregion of the ARS known 
b  d  as the 45 pocket (19) or pocket B (20).  The K~La chimera 
b  and K  share the same amino acid at position 22 but differ 
b  a  from each other at position 24.  K~L~ has the same amino 
acid (Ser) as K bins at residue 24. To determine whether struc- 
tural similarities  in pocket B along with sequence identity 
in the helices of the ARS might be sufficient to cause alloan- 
tigenic crossreactivity, B6 anti-bm8 CTL were tested for their 
ability to lyse KbL~. As shown in Fig. 4, B6 anti-bin8 CTL 
lysed targets expressing K bms and K~L~ efficiently,  but failed 
to  lyse  cells  expressing  K b and  L a.  Therefore,  structural 
similarity in pocket B along with the ot helices was sufficient 
to form shared alloantigenic  epitopes. 
CTL sublines from a B6 anti-bm8 CTL culture were es- 
tablished by limiting dilution at five cells/well to determine 
the contribution of amino acids 22 and 24 in the generation 
of alloantigenic specificities  shared by K bm8 and K~L~.  Four 
of six sublines that lysed KbmS-expressing L cells specifically 
also lysed cells expressing K~L~ (data not shown). However, 
the fine specificity of these clones was not uniform.  Some 
sublines characterized by 2D1 lysed L cells expressing a variant 
of the K b molecule containing  a single bm8-1ike substitu- 
tion at position 24, while others, as line 3F1, required bm8- 
like substitutions at both positions 22 and 24 (Fig. 5). Our 
interpretation of these observations is that structural similar- 
ities in pocket B are sufficient to permit a set of similar or 
identical peptides to bind both molecules generating cross- 
reactive alloantigenic  specificities  in the context  of the K b 
helices. 
Discussion 
A class I chimeric molecule was created to analyze the rel- 
ative contributions of the ot helices  and 3  sheets of the an- 
tigen recognition site in determining the antigenic structures 
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Figure  4.  K b  anti-K  bins CTL 
lyse L cells expressing K~L~. B6 
spleen cells were used to generate 
CTL  specific for K bins in vitro. 
The cells were used to analyze a 
panel of transfected L  cells. 
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Figure 5.  CTL lines that crossreact with K bins and K~L~ have different 
fine specificities. CTL sublines were established  by limiting dilution at 
five cells/well  and tested against cotransfected  L cell targets that included 
partial variants (site-directed  mutants) of the bm8 mutant. Two represen- 
tative K b anti-bm8 CTL lines (2-D1 and 3F1) are shown. The target cells 
include partial variants of bin8 generated by site-directed  mutagenesis. 
Kbm8-23, 30 is K b with bm8 amino acid changes at the silent positions 
23 and 30. Kbm8-22 is K b with the bm8 amino acid change at position 
22. This change produces a minor alloreactive determinant. Kbm8-24 is 
K b with the bm8 amino acid change at position 24. This change produces 
a major alloreactive  determinant. 
that interact with TCRs during allorecognition. Alloreac- 
tive CTL populations specific for molecules that shared se- 
quences forming the c~ helices or the/3 sheets with the chi- 
meric target were used to establish whether T cells recognize 
structures determined by the ot helices alone, or whether the 
contact  points between  TCRs  and  class  I  molecules are 
influenced directly or indirectly by the amino acids on the 
floor of the antigen binding site. A variety of alloresponsive 
CTL raised in vitro against spleen cells bearing class I alloan- 
tigens that shared either the ol helices (K  b) or the/3 sheet 
structures (Ld), but not both with the chimeric class I mol- 
ecule were not able to lyse targets expressing the chimeric 
glycoprotein. Our interpretation of these experiments is that 
the alloresponse is primarily directed against structures formed 
by interaction with both the/3 sheets and the c~ helices of 
the ARS. We take the fact that conformationally sensitive 
antibody epitopes associated with the K b ot helices are re- 
tained in the chimera to mean that the surface of the engineered 
molecule is not greatly perturbed by interactions of the cr 
helices with the extensive structural differences located in the 
/3 sheets of the hybrid ARS. Therefore, we find the CTL 
data to support the view that the alloresponse is generated 
by  T  cells  recognizing alloantigenic  structures  that  are 
influenced by peptides bound to ARS and that epitopes pri- 
marily determined by the class I heavy chain play, at most, 
a minor role in alloantigenicity. 
The array of peptides and the orientation of their side chains 
are determined by the polymorphic amino acids that line the 
floor (/3 sheets) and wall (o~ helices) of the ARS. By altering 
each of the polymorphic positions in the/3 sheets in the gener- 
ation of the KbL~ chimera, virtually all crossreactivity with 
CTL specific against the K b molecule was abolished.  The 
observation that CTL raised  against  the alloantigen K bms 
crossreacted strongly with cells expressing the chimeric al- 
loantigen further supports this view. In addition to the K b 
(~ helices, K bins shares a single polymorphic position on the 
floor of the ARS with KbL~. The high degree of crossreac- 
tivity between K bin8 and Kb~L~ is remarkable in light of the 
remaining high degree of the structural dissimilarity along 
the B sheets of the two antigen-presenting molecules. It ap- 
pears that shared structural properties around position 24 pro- 
vide a dominant binding site that influences peptide selec- 
tion and that the orientation of the peptides with respect 
to the TCR is determined in this case primarily by the o~ 
helices. This site may be pocket B since K~L~ share iden- 
tical residues lining the pocket. We would predict from these 
findings that there is extensive sharing of peptides between 
K bms and K~L~,b  a  a hypothesis that will be tested in future 
experiments. 
Other studies have addressed whether alloreactive T cells 
are capable of recognizing MHC molecules directly or whether 
they are focused on the peptides oriented in the antigen rec- 
ognition site of the molecules. Several of these have concluded 
that T ceils can recognize diversity in the class I heavy chains 
directly. In one analysis, class I molecules were denatured and 
separated  into  their  heavy  chain  and  /32-microglobulin 
subunits (21). Upon renaturation of the heavy chain with 
excess/32-microglobulin,  molecules were recovered that re- 
tained conformationally sensitive serologic epitopes and the 
ability to stimulate an allospecific CTL line. Another study 
addressed this issue by reducing the frequency of antigen- 
presenting molecules containing alloantigenic peptides on the 
cell surface and by assessing the impact of the changes on 
alloantigenicity (22). In still another report, the variant cell 
line RMA-S was analyzed for its antigen-presenting proper- 
ties, and a distinction was observed in the ability of RMA-S 
cells to induce immunity and to serve as a target for CTL 
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These findings suggested that processing of minor class I-re- 
stricted antigens was an essential step, whereas, not all major 
alloantigenic epitopes resulted from processing of peptides. 
Each of these studies was interpreted in support of the hy- 
pothesis that allospecific CTL normally recognize structures 
determined directly by the polymorphic class I heavy chains. 
In contrast, another set of studies argued strongly for a 
central role of cellular peptides in determining alloantigenic 
specificity (24). Human variant cell lines displaying deficien- 
cies in class I antigen processing, similar to those seen in the 
RMA-S ceUs (25,  26), were used to evaluate the nature of 
structures recognized by alloresponsive CTL. The T2 hybrid 
cell and its transfected  derivatives  express class I  antigen- 
presenting molecules on the cell surface (27). In contrast to 
the experimental system using RMA-S cells (23),  alloreac- 
tire CTL generated in mixed lymphocyte cultures that were 
specific for the alloantigen K b in the context of normal ceUs 
were not reactive with Kb-transfected targets (24). The ina- 
bility of CTL to recognize the T2-K  b line could have been 
due to either destabilization of the antigen binding domain 
of K b as a resuh of the absence of available peptides in the 
ARS  and/or  because  peptides  provide  the  alloantigenic 
specificity recognized by allospecific CTL. This unrespon- 
siveness was reversed for a majority of the CTL lines by the 
addition of peptide preparations generated from cell lysates 
to the T2-derived target cells. Furthermore, the addition of 
sdected peptides known to bind appropriately to the antigen- 
presenting molecules on the T2 cells failed to restore aUoan- 
tigenicity. This latter finding was taken as evidence that the 
peptides were not solely providing stability to empty class 
I molecules, but were contributing specificity to the anti- 
genic complex. The observation that a substantial portion 
of the alloresponse  was specific for peptides in the context 
of non-sdf-dass I is most consistent with the peptide model. 
What is the basis for the disagreements emanating from 
these studies? One possibility is that the experimental manipu- 
lations varied in the degree they achieved the intended dis- 
tinction between class I molecules containing a broad spec- 
trum of peptides and those that contained either no peptide 
or defined peptides. While RMA-S cells and T2 cells appear 
to contain similar phenotypes (25,  26),  it is not dear that 
their genetic lesions are identical, nor is it dear that the mouse 
and human antigen processing machinery is similarly sensi- 
tive to such mutations. Therefore, it is plausible that pro- 
cessing mutations may differentially influence the spectrum 
or quantity of peptides available to class I antigen-presenting 
molecules in the two systems. The study by Mfillbaker  et 
al.  (22) used even more indirect approaches,  attempting to 
displace peptides with high a~nity peptide competitors or 
to disrupt antigen processing with viral infections. Although 
these techniques are designed to displace alloantigenic pep- 
tides,  none of these  approaches  can  be  presumed 100% 
ef~cient.  We have attempted to circumvent these problems 
by introducing structural changes in the floor of the ARS 
of antigen-presenting  molecules, an approach that assures that 
each expressed molecule is modified experimentally. 
The same limitations probably do not apply to the study 
by Elliot and Eisen (21), although, as addressed in their study, 
the possible  significance of residual peptide contamination 
in the system was dif~cult to assess. It would be interesting 
to see whether the renatured A2 molecules were capable of 
stimulating a wide variety of A2-spedfic CTL clones  or 
whether the panning technique (28) used in the study skewed 
the A2-responsive  T  cell line,  A2p. 
Whatever  the reasons  behind these disagreements, the 
identification of CTL that crossreacts with structurally dis- 
similar alloantigens underscores the complexity of the factors 
determining T  cell recognition of MHC class I molecules. 
A CTL clone has been isolated that crossreacts with two al- 
loantigens,  K b~  and  L  d (29).  These glycoproteins differ 
from each other not only at each polymorphic position on 
the fl sheets that form the floor of the ARS, but also at 10 
polymorphic positions on the helices. Despite the fact that 
T  cells of this nature exist,  we have not found them to be 
a measurable  fraction of T  cells generated in alloresponses 
against either the K bm3 or L d antigens (Z.  Cai and L. R. 
Pease, unpublished observation); nor in our analysis of K b 
aUoantigenicity have we found significant numbers of CTL 
with receptors specific for structures determined by the oe 
helices alone. 
Our current view of the structural basis of the immune 
response against class I major transplantation antigens is that 
T cells primarily recognize determinants formed in associa- 
tion with peptides presented by non-self-antigen-presenting 
molecules. Structural diversity in the c~ helices and fl sheets 
that form the antigen binding site influences the array of cel- 
lular peptides selected for presentation, and the profiles of 
the peptides that are exposed to the TCR. T cells probably 
also simuhaneously recognize structures determined by the 
class I heavy chains (30). These associations have been demon- 
strated using peptides comprised of amino acid sequences in 
and around the ARS to inhibit CTL recognition of aUoan- 
tigens (31-32). Some aspects of this direct recognition of the 
class I heavy chain by the TCR appears to be determined 
by conserved structures of the antigen-presenting molecules 
(31), while others involve positions of diversity in the heavy 
chain (32).  In the event that these polymorphic structures 
permit strong interactions with elements of the T cell reper- 
toire,  aUospecific CTL with little  specificity  for peptide- 
determined epitopes may be generated. While TCRs may 
exist that can recognize class I alloantigens in a manner inde- 
pendent of bound peptides, cells bearing these receptors do 
not appear to comprise a significant portion of aUoresponses 
generated in mixed lymphocyte culture. 
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